Search research articles
Contact Us
Filters
Showing results (21-30 of 167) with videos related to
Page
of 17
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 19, 2003
Benign CD10-positive T cells in reactive lymphoid proliferations and B-cell lymphomas
James R Cook, Fiona E Craig, Steven H Swerdlow
American Journal of Clinical Pathology
|
June 17, 2004
Utility of routine classical cytogenetic studies in the evaluation of suspected lymphomas: results of 279 consecutive lymph node/extranodal tissue biopsies
James R Cook, Sofia Shekhter-Levin, Steven H Swerdlow
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2008
Mucosa-associated lymphoid tissue lymphoma of the cervix
Devin Coon, Sushil Beriwal, Steven H Swerdlow, et al.
The New England Journal of Medicine
|
October 11, 2018
Venetoclax in a Patient with a Blastic Plasmacytoid Dendritic-Cell Neoplasm
Mounzer E Agha, Sara A Monaghan, Steven H Swerdlow
International Journal of Clinical and Experimental Pathology
|
July 29, 2009
Comparison of Bcl-2, CD38 and ZAP-70 Expression in Chronic Lymphocytic Leukemia
Rachel L Sargent, Fiona E Craig, Steven H Swerdlow
The American Journal of Surgical Pathology
|
October 17, 2014
Robert Deaver Collins (1928-2013): a life dedicated to teaching, investigation, and concern for human beings and our earth
Marsha C Kinney, John B Cousar, Steven H Swerdlow
Human Pathology
|
August 31, 2017
J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
Erika M Moore, Steven H Swerdlow, Sarah E Gibson
Human Pathology
|
February 5, 2011
Natural killer cell subsets and natural killer-like T-cell populations in benign and neoplastic B-cell proliferations vary based on clinicopathologic features
Sarah E Gibson, Steven H Swerdlow, Raymond E Felgar
American Journal of Clinical Pathology
|
June 14, 2014
Utility of CD279/PD-1 immunohistochemistry in the evaluation of benign and neoplastic T-cell-rich bone marrow infiltrates
Christopher H Cogbill, Steven H Swerdlow, Sarah E Gibson
Human Pathology
|
January 24, 2006
The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma
Lorinda A Soma, Fiona E Craig, Steven H Swerdlow
Page
of 17
Search research articles
Search
Showing results (21-30 of 167) with videos related to
Sort By:
Page
of 17
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 19, 2003
Benign CD10-positive T cells in reactive lymphoid proliferations and B-cell lymphomas
James R Cook, Fiona E Craig, Steven H Swerdlow
American Journal of Clinical Pathology
|
June 17, 2004
Utility of routine classical cytogenetic studies in the evaluation of suspected lymphomas: results of 279 consecutive lymph node/extranodal tissue biopsies
James R Cook, Sofia Shekhter-Levin, Steven H Swerdlow
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2008
Mucosa-associated lymphoid tissue lymphoma of the cervix
Devin Coon, Sushil Beriwal, Steven H Swerdlow, et al.
The New England Journal of Medicine
|
October 11, 2018
Venetoclax in a Patient with a Blastic Plasmacytoid Dendritic-Cell Neoplasm
Mounzer E Agha, Sara A Monaghan, Steven H Swerdlow
International Journal of Clinical and Experimental Pathology
|
July 29, 2009
Comparison of Bcl-2, CD38 and ZAP-70 Expression in Chronic Lymphocytic Leukemia
Rachel L Sargent, Fiona E Craig, Steven H Swerdlow
The American Journal of Surgical Pathology
|
October 17, 2014
Robert Deaver Collins (1928-2013): a life dedicated to teaching, investigation, and concern for human beings and our earth
Marsha C Kinney, John B Cousar, Steven H Swerdlow
Human Pathology
|
August 31, 2017
J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
Erika M Moore, Steven H Swerdlow, Sarah E Gibson
Human Pathology
|
February 5, 2011
Natural killer cell subsets and natural killer-like T-cell populations in benign and neoplastic B-cell proliferations vary based on clinicopathologic features
Sarah E Gibson, Steven H Swerdlow, Raymond E Felgar
American Journal of Clinical Pathology
|
June 14, 2014
Utility of CD279/PD-1 immunohistochemistry in the evaluation of benign and neoplastic T-cell-rich bone marrow infiltrates
Christopher H Cogbill, Steven H Swerdlow, Sarah E Gibson
Human Pathology
|
January 24, 2006
The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma
Lorinda A Soma, Fiona E Craig, Steven H Swerdlow
Page
of 17